Hepatology forum. 2021 Sep 15;2(3):102-106. doi: 10.14744/hf.2021.2021.0029 Q32.12025

The effect of transarterial chemoembolization therapy on survival in patients with non-resectable hepatocellular carcinoma: Single-center study results

肝动脉化疗栓塞治疗不可手术切除的原发性肝癌患者生存效果的单中心研究结果分析 翻译改进

作者单位 +展开

DOI: 10.14744/hf.2021.2021.0029 PMID: 35784908

摘要 Ai翻译

Copyright © Hepatology forum. 中文内容为AI机器翻译，仅供参考！

相关内容

• Impact of Early Lenvatinib Administration on Survival in Patients with Intermediate-Stage Hepatocellular Carcinoma: A Multicenter, Inverse Probability Weighting Analysis

  仑伐替尼早期使用对中度肝细胞癌患者生存影响的多中心逆概率加权分析

  Toshifumi Tada et al.

  Oncology. 2021;99(8):518-527.

• Preoperative blood neutrophil count predicts survival in hepatocellular carcinoma patients with living donor liver transplantation

  术前中性粒细胞计数可预测活体肝移植肝癌患者的生存率

  Young Mi Hong et al.

  Korean journal of transplantation. 2020 Jun 30;34(2):92-99.

• Hepatocellular Carcinoma Survival by Etiology: A SEER-Medicare Database Analysis

  肝细胞癌生存率与病因的关系：基于SEER-Medicare数据库的分析

  Gagandeep Brar et al.

  Hepatology communications. 2020 Aug 9;4(10):1541-1551.

• High expression of p300 in HCC predicts shortened overall survival in association with enhanced epithelial mesenchymal transition of HCC cells

  HCC中p300高表达预示总生存期缩短并与HCC上皮间质转化增强相关

  Chihiro Yokomizo et al.

  Cancer letters. 2011 Nov 28;310(2):140-7.

• Use of inhibitors of the renin-angiotensin system is associated with longer survival in patients with hepatocellular carcinoma

  肾素血管紧张素系统抑制剂的使用与肝细胞癌患者的生存期延长有关

  Matthias Pinter et al.

  United European gastroenterology journal. 2017 Nov;5(7):987-996.

• Tumoural Expression of Connective Tissue Growth Factor (CTGF) Impacts on Survival in Patients Diagnosed with Hepatocellular Carcinoma (HCC)

  细胞外基质成分连接组织生长因子对肝癌患者生存影响的研究

  Angela Lamarca et al.

  Current cancer drug targets. 2015;15(5):435-44.

• Impact of the Interval between Transarterial Chemoembolization Sessions on Survival in Patients with Unresectable Hepatocellular Carcinoma

  不可切除肝细胞癌患者经动脉化疗栓塞治疗间隔时间对生存期的影响分析

  Hyung-Don Kim et al.

  Journal of vascular and interventional radiology : JVIR. 2016 Apr;27(4):504-13.

• Multimodal and sequential treatment improves survival in patients with hepatocellular carcinoma

  多模式及序贯治疗可改善肝细胞癌患者预后

  Thomas Göbel et al.

  Zeitschrift fur Gastroenterologie. 2017 Mar;55(3):251-259.